Technical / White Paper

The World is Changing, Talk to Marken

Published

Format: PDF file | Document type: Technical / White Paper

marken

The landscape of the clinical trial supply chain is changing throughout the world. Patient centricities and immune, cell and gene therapies are now the foundation of most treatments methods. The new EU regulations and Good Distribution Practices (GDP) guidelines, along with the industry’s need to decrease cost, reduce time to market and a harmonization of rules call for radical changes in the way trials are conducted.

Latest content from Marken: Global Life Science Supply Chain Solutions

How companies are realizing the potential of virtual and hybrid clinical trials

Content provided by Marken: Global Life Science Supply Chain Solutions

How companies are realizing the potential of virtual and hybrid clinical trials

Virtual and hybrid clinical trials have arrived. Having learnt from pilot projects, pharma companies are systematically incorporating patient-centric services into trials, resulting in a significant minority of today’s studies featuring virtual elements....

Related resources from Marken: Global Life Science Supply Chain Solutions

Show more

Supplier info centre